Oscar Lahoud

1.6k total citations
44 papers, 197 citations indexed

About

Oscar Lahoud is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Oscar Lahoud has authored 44 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 14 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Oscar Lahoud's work include Multiple Myeloma Research and Treatments (25 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Oscar Lahoud is often cited by papers focused on Multiple Myeloma Research and Treatments (25 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Oscar Lahoud collaborates with scholars based in United States, United Kingdom and Sweden. Oscar Lahoud's co-authors include Heather Landau, Daniel D. Mikol, Madanamohan Boyanapalli, Sergio Giralt, Parastoo B. Dahi, Ludwine Messiaen, Sita Somara, Bhumsoo Kim, Hani Hassoun and David J. Chung and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Oscar Lahoud

38 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oscar Lahoud United States 8 99 89 70 42 35 44 197
Morie A. Gertz United States 4 166 1.7× 151 1.7× 80 1.1× 24 0.6× 59 1.7× 6 251
Terukazu Enami Japan 10 76 0.8× 76 0.9× 53 0.8× 39 0.9× 21 0.6× 16 225
Rebecca L. Zon United States 5 150 1.5× 44 0.5× 27 0.4× 26 0.6× 14 0.4× 15 228
Yusuke Isshiki Japan 9 98 1.0× 69 0.8× 23 0.3× 29 0.7× 15 0.4× 20 162
Tim Heffernan United States 5 101 1.0× 22 0.2× 41 0.6× 19 0.5× 8 0.2× 6 202
Margherita Vieri Germany 10 140 1.4× 54 0.6× 27 0.4× 22 0.5× 10 0.3× 27 244
Ioanna Dialoupi Greece 9 140 1.4× 106 1.2× 61 0.9× 46 1.1× 8 0.2× 23 197
Kenneth Anderson United States 7 75 0.8× 125 1.4× 52 0.7× 24 0.6× 4 0.1× 14 205
Seongmin Choi South Korea 10 115 1.2× 9 0.1× 35 0.5× 26 0.6× 17 0.5× 19 226
Bettina R. Bonn Germany 7 73 0.7× 19 0.2× 95 1.4× 46 1.1× 26 0.7× 9 224

Countries citing papers authored by Oscar Lahoud

Since Specialization
Citations

This map shows the geographic impact of Oscar Lahoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar Lahoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar Lahoud more than expected).

Fields of papers citing papers by Oscar Lahoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar Lahoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar Lahoud. The network helps show where Oscar Lahoud may publish in the future.

Co-authorship network of co-authors of Oscar Lahoud

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar Lahoud. A scholar is included among the top collaborators of Oscar Lahoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar Lahoud. Oscar Lahoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Islam, Shahidul, et al.. (2024). Characterization and Comparative Outcomes of Younger Multiple Myeloma Patients. Blood. 144(Supplement 1). 5155–5155.
4.
Fein, Joshua, Sean M. Devlin, Gonca Ozcan, et al.. (2024). A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation. Leukemia & lymphoma. 66(4). 713–720.
5.
Maclachlan, Kylee, Neha Korde, Sham Mailankody, et al.. (2024). Evaluating serum free light chain ratio as a biomarker in multiple myeloma. Haematologica. 110(2). 493–497.
6.
Derkach, Andriy, Billel Gasmi, Theodora Anagnostou, et al.. (2023). T-Cell Exhaustion Signature Predicts Early Relapse after Autologous Stem Cell Transplant for Multiple Myeloma: BMT CTN 0702 Secondary Immune Analysis. Blood. 142(Supplement 1). 3326–3326. 1 indexed citations
7.
Firestone, Ross, Andriy Derkach, Kylee Maclachlan, et al.. (2023). P-486 Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 23. S307–S308. 1 indexed citations
8.
Scordo, Michael, Leah Gilbert, Jessica Flynn, et al.. (2022). Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation. Blood Advances. 7(8). 1536–1544. 4 indexed citations
9.
Hultcrantz, Malin, Even H. Rustad, Venkata Yellapantula, et al.. (2022). Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma. Clinical Cancer Research. 28(10). 2160–2166. 1 indexed citations
10.
Dahi, Parastoo B., Andrew Lin, Michael Scordo, et al.. (2022). Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(8). 485.e1–485.e6. 1 indexed citations
11.
Korde, Neha, Malin Hultcrantz, Hani Hassoun, et al.. (2022). Clinical efficacy of daratumumab (DARA)-based second line therapy after DARA-containing and DARA-free induction therapies in multiple myeloma: A single center experience.. Journal of Clinical Oncology. 40(16_suppl). e20005–e20005. 1 indexed citations
12.
Tan, Carlyn, Andriy Derkach, Malin Hultcrantz, et al.. (2022). Carfilzomib, Lenalidomide and Dexamethasone (KRd) Vs Bortezomib, Lenalidomide, and Dexamethasone (VRd) As Induction Therapy in Newly Diagnosed High-Risk Multiple Myeloma. Blood. 140(Supplement 1). 1817–1819. 3 indexed citations
13.
Lahoud, Oscar, Sean M. Devlin, Molly Maloy, et al.. (2021). Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter’s transformation. Blood Advances. 5(14). 2879–2889. 18 indexed citations
14.
Shah, Gunjan L., Raymond E. Baser, Michael Scordo, et al.. (2020). Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma. Biology of Blood and Marrow Transplantation. 26(11). 2040–2046. 1 indexed citations
15.
16.
Landau, Heather, Oscar Lahoud, Sean M. Devlin, et al.. (2019). Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis. Biology of Blood and Marrow Transplantation. 26(1). 204–208. 11 indexed citations
17.
Lahoud, Oscar, et al.. (2015). Artesunate-related fever and delayed hemolysis in a returning traveler. SHILAP Revista de lepidopterología. 2(2). 63–65. 7 indexed citations
18.
Lahoud, Oscar, Craig S. Sauter, Paul A. Hamlin, & Parastoo B. Dahi. (2015). High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma. Current Oncology Reports. 17(9). 42–42. 11 indexed citations
19.
20.
Boyanapalli, Madanamohan, et al.. (2005). Oligodendrocyte‐myelin glycoprotein is present in lipid rafts and caveolin‐1‐enriched membranes. Glia. 52(3). 219–227. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morie A. Gertz Breakdown of academic impact, for papers by Terukazu Enami Breakdown of academic impact, for papers by Rebecca L. Zon Breakdown of academic impact, for papers by Yusuke Isshiki Breakdown of academic impact, for papers by Tim Heffernan Breakdown of academic impact, for papers by Margherita Vieri Breakdown of academic impact, for papers by Ioanna Dialoupi Breakdown of academic impact, for papers by Kenneth Anderson Breakdown of academic impact, for papers by Seongmin Choi Breakdown of academic impact, for papers by Bettina R. Bonn
Rankless by CCL
2026